ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 298

$502K Total Retail Price of All Prescriptions

Rank: 32 out of 298

421 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 696 684 1 2
FUROSEMIDE 392 364 2 5
LEVOTHYROXINE SODIUM 352 341 3 1
OMEPRAZOLE 347 340 4 3
METFORMIN HCL 319 309 5 10
ATENOLOL 279 265 6 16
HYDROCHLOROTHIAZIDE 267 247 7 13
WARFARIN SODIUM 245 245 8 7
AMLODIPINE BESYLATE 237 223 9 6
HYDROCODONE-ACETAMINOPHEN 226 190 S3 10 8
POLYETHYLENE GLYCOL 3350 226 226 10 29
LISINOPRIL 215 215 12 4
BENAZEPRIL HCL 213 197 13 52
METOPROLOL SUCCINATE 210 201 14 12
PREDNISONE 198 196 15 33
POTASSIUM CHLORIDE 194 175 16 11
KLOR-CON 10 143 138 17 61
DIGOXIN 140 140 18 27
NAMENDA 134 134 19 35
CITALOPRAM HBR 111 111 20 17
FLUTICASONE PROPIONATE 106 98 21 38
TAMSULOSIN HCL 104 92 22 24
CARBIDOPA-LEVODOPA 98 98 23 49
DONEPEZIL HCL 95 95 24 22
CLOPIDOGREL 94 94 25 36
BENAZEPRIL-HYDROCHLOROTHIAZIDE 92 88 26 173
AZITHROMYCIN 87 84 27 63
DIOVAN 84 84 28 47
ZOLPIDEM TARTRATE 82 77 29 25
ALLOPURINOL 82 72 29 28
SERTRALINE HCL 82 76 29 19
FENOFIBRATE 80 70 32 62
FLUOXETINE HCL 79 64 33 50
CARVEDILOL 74 74 34 23
DIOVAN HCT 71 71 35 130
TRIAMTERENE-HCTZ 70 68 36 43
PLAVIX 70 70 36 70
CRESTOR 67 67 38 26
GLYBURIDE 64 64 R 39 76
PROAIR HFA 61 61 40 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 40 30
LEVOFLOXACIN 60 57 42 101
NAPROXEN 59 54 43 148
METOPROLOL TARTRATE 59 59 43 9
CIPROFLOXACIN HCL 59 57 43 56
ALENDRONATE SODIUM 57 57 46 21
FENTANYL 57 55 S2 46 32
ATORVASTATIN CALCIUM 55 55 48 14
LOSARTAN POTASSIUM 55 55 48 18
NITROGLYCERIN PATCH 51 51 50 106
FORTICAL 50 50 51 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.